Is there transparency in the pricing of medicines in the South African private sector

Recent investigations by the Competition Commission of South Africa (SA) of suspected excessive pricing of cancer medicines in SA by three global pharmaceutical companies have once again drawn attention to increasing medicine pricing transparency and warrant further public debate.

Bibliographic Details
Main Authors: V Bangalee, F Suleman
Format: Article
Language:English
Published: Health and Medical Publishing Group 2018-02-01
Series:South African Medical Journal
Online Access:http://www.samj.org.za/index.php/samj/article/download/12200/8381